Legal & General Group’s RAPT Therapeutics RAPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,379
| Closed | -$2.9K | – | 3515 |
|
|
2025
Q1 | $2.9K | Hold |
2,379
| – | – | ﹤0.01% | 3330 |
|
|
2024
Q4 | $3.76K | Hold |
2,379
| – | – | ﹤0.01% | 3360 |
|
|
2024
Q3 | $4.78K | Hold |
2,379
| – | – | ﹤0.01% | 3372 |
|
|
2024
Q2 | $7.23K | Sell |
2,379
-13,739
| -85% | -$41.8K | ﹤0.01% | 3348 |
|
|
2024
Q1 | $145K | Sell |
16,118
-4,849
| -23% | -$43.5K | ﹤0.01% | 2714 |
|
|
2023
Q4 | $521K | Sell |
20,967
-80
| -0.4% | -$1.99K | ﹤0.01% | 2434 |
|
|
2023
Q3 | $350K | Buy |
21,047
+1,214
| +6% | +$20.2K | ﹤0.01% | 2569 |
|
|
2023
Q2 | $371K | Buy |
19,833
+7,607
| +62% | +$142K | ﹤0.01% | 2557 |
|
|
2023
Q1 | $224K | Buy |
12,226
+1,948
| +19% | +$35.7K | ﹤0.01% | 2551 |
|
|
2022
Q4 | $204K | Buy |
10,278
+1,268
| +14% | +$25.1K | ﹤0.01% | 2601 |
|
|
2022
Q3 | $217K | Buy |
9,010
+545
| +6% | +$13.1K | ﹤0.01% | 2592 |
|
|
2022
Q2 | $155K | Buy |
8,465
+1,377
| +19% | +$25.2K | ﹤0.01% | 2726 |
|
|
2022
Q1 | $156K | Sell |
7,088
-23
| -0.3% | -$506 | ﹤0.01% | 2754 |
|
|
2021
Q4 | $261K | Buy |
7,111
+45
| +0.6% | +$1.65K | ﹤0.01% | 2607 |
|
|
2021
Q3 | $220K | Buy |
7,066
+4,019
| +132% | +$125K | ﹤0.01% | 2655 |
|
|
2021
Q2 | $96K | Buy |
3,047
+653
| +27% | +$20.6K | ﹤0.01% | 2753 |
|
|
2021
Q1 | $53K | Buy |
2,394
+1,055
| +79% | +$23.4K | ﹤0.01% | 2799 |
|
|
2020
Q4 | $26K | Hold |
1,339
| – | – | ﹤0.01% | 2992 |
|
|
2020
Q3 | $43K | Sell |
1,339
-469
| -26% | -$15.1K | ﹤0.01% | 2748 |
|
|
2020
Q2 | $52K | Buy |
1,808
+1,541
| +577% | +$44.3K | ﹤0.01% | 2720 |
|
|
2020
Q1 | $5K | Hold |
267
| – | – | ﹤0.01% | 3268 |
|
|
2019
Q4 | $7K | Buy |
+267
| New | +$7K | ﹤0.01% | 3324 |
|